Explore more publications!
Industry Reporter: Massachusetts
Got News to Share?

Industry Reporter: Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Reporter: Massachusetts.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on November 3, 2025

Joined Bio Acquires DNAsimple to Create Industry's Most Comprehensive Patient-Powered Research Platform
November 3, 2025

Joined Bio Acquires DNAsimple to Create Industry's Most Comprehensive Patient-Powered Research Platform

Indeterminate EIN Presswire
Kula Bio Finalizes Series A-1 Funding Round and Announces Executive Leadership Transitions
November 3, 2025

Kula Bio Finalizes Series A-1 Funding Round and Announces Executive Leadership Transitions

Indeterminate EIN Presswire
Atlantica Announces Pricing of Additional $285 Million of 6.375% Green Senior Notes due 2032
November 3, 2025

Atlantica Announces Pricing of Additional $285 Million of 6.375% Green Senior Notes due 2032

Indeterminate GlobeNewswire
Douglas Dynamics Reports Third Quarter 2025 Results
November 3, 2025

Douglas Dynamics Reports Third Quarter 2025 Results

Indeterminate GlobeNewswire
CTS Corporation to Participate in the Southwest IDEAS Conference
November 3, 2025

CTS Corporation to Participate in the Southwest IDEAS Conference

Indeterminate GlobeNewswire
PTL Limited Announces Financial Results for the First Half of Fiscal Year 2025
November 3, 2025

PTL Limited Announces Financial Results for the First Half of Fiscal Year 2025

Indeterminate GlobeNewswire
ALPHAMIN ANNOUNCES CAD $0.04 PER SHARE SECOND INTERIM FY2025 DIVIDEND / FILES Q3 2025 FINANCIAL STATEMENTS AND MD&A
November 3, 2025

ALPHAMIN ANNOUNCES CAD $0.04 PER SHARE SECOND INTERIM FY2025 DIVIDEND / FILES Q3 2025 FINANCIAL STATEMENTS AND MD&A

Indeterminate GlobeNewswire
Unitil Releases Corporate Sustainability and Responsibility Report
November 3, 2025

Unitil Releases Corporate Sustainability and Responsibility Report

Indeterminate GlobeNewswire
Douglas Dynamics Acquires the Assets of Venco Venturo Industries LLC
November 3, 2025

Douglas Dynamics Acquires the Assets of Venco Venturo Industries LLC

Indeterminate GlobeNewswire
Challenger Energy Group plc Acquisition an Update Letter to Shareholders
November 3, 2025

Challenger Energy Group plc Acquisition an Update Letter to Shareholders

Indeterminate GlobeNewswire
AmpliTech Group Issues Free Writing Prospectus Providing Additional Details of its 2025 Unit Rights Offering and its 5G ORAN Growth Opportunity
November 3, 2025

AmpliTech Group Issues Free Writing Prospectus Providing Additional Details of its 2025 Unit Rights Offering and its 5G ORAN Growth Opportunity

Indeterminate GlobeNewswire
Granting of Incentive Stock Options
November 3, 2025

Granting of Incentive Stock Options

Indeterminate GlobeNewswire
MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selling Brands to New Markets and Customers
November 3, 2025

MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selling Brands to New Markets and Customers

Indeterminate GlobeNewswire
McEwen Q3 2025 Results Conference Call
November 3, 2025

McEwen Q3 2025 Results Conference Call

Indeterminate GlobeNewswire
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 3, 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
BexBack Launches Double Deposit Bonus Campaign to Empower Crypto Futures Traders During High-Volatility Market
November 3, 2025

BexBack Launches Double Deposit Bonus Campaign to Empower Crypto Futures Traders During High-Volatility Market

Indeterminate GlobeNewswire
Cabot Corp Reports Fourth Quarter and Fiscal Year 2025 Results
November 3, 2025

Cabot Corp Reports Fourth Quarter and Fiscal Year 2025 Results

Indeterminate GlobeNewswire
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 3, 2025

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Cabot Corporation Appoints Robert Rist as Vice President of Investor Relations and Corporate Planning
November 3, 2025

Cabot Corporation Appoints Robert Rist as Vice President of Investor Relations and Corporate Planning

Indeterminate GlobeNewswire
Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU
November 3, 2025

Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions